Abstract
GBM Cancer stem cells (CSCs) are responsible for growth, recurrence and resistance to chemo- and radio-therapy. They are supposed to originate from the transformation of Neural stem cells (NSC) of the Sub-ventricular zone (SVZ) or Sub-granular zone (SGZ) of hippocampus. Alternatively, they can be the expression of a functional status of competence or dedifferentiated cells of the tumor re-acquiring stemness properties. The origin of gliomas has been put in relation with the primitive neuroepithelial cells of the SVZ or NSC or progenitors, as showed by the development of experimental tumors in rats by transplacental ethylnitrosourea administration. The demonstration of CSCs in GBM is based on Neurosphere (NS) and Adherent cell (AC) development in culture. NS share the same genetic alterations with primary tumors and express stemness antigens, whereas AC show differentiation antigens. NS are generated by the most malignant areas of GBM. CSCs are considered at the top of a hierarchy of tumor cells of which the most immature are Nestin+/CD133– cells or established on the basis of EGFR amplification or delta-EGFR. NS in serum conditions differentiate and give origin to AC, the real nature of which is still a matter of discussion. Cells in culture could be simply in vitro entities depending on culture methodology. CSCs in GBM could be tumor cells at the end of a dedifferentiation process re-acquiring stemness properties, in an opposite way to what is realized in normal cytogenesis, where stemness is lost progressively with cell differentiation. This interpretation could fit with the origin of the two GBM types, primary and secondary. In primary GBM the tumor originates directly from stem cells or progenitors from SVZ with an accelerated transformation, whereas secondary GBM originates by transformation from astrocytomas arisen through a slow transformation from migrating stem cells and progenitors.
Highlights
In the last decade a tremendous amount of contributions has been dedicated to the problem of Cancer stem cells (CSCs)
We wanted in this study to discuss the nature of CSCs on the basis of our experience of neuropathologists/neuro-oncologists based on the daily practice with CSCs in the context of diagnosis, genesis and prognosis of gliomas
There is a co-regulation between Neural stem cells (NSC) and vessels [19,20] and the same happens between microvasculature, cell proliferation and aggressiveness in GBM tumoral niches where stem cells through Vascular endothelial growth factor
Summary
In the last decade a tremendous amount of contributions has been dedicated to the problem of Cancer stem cells (CSCs). In Glioblastoma (GBM) they have been repeatedly demonstrated, interpreted and discussed in relation with the methodology of culture and the starting concepttual viewpoint of the authors. Depending on their attitude as specialists of the field, pathologists/neuro-pathologists, neurobiologists or researchers using in vitro culture CSCs for resolving neuro-oncological problems, different opinions have been put forward going from CSCs as a special cell type to CSCs as a functional state or a sheer product of the culture. We wanted in this study to discuss the nature of CSCs on the basis of our experience of neuropathologists/neuro-oncologists based on the daily practice with CSCs in the context of diagnosis, genesis and prognosis of gliomas
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
